Revealing the unusual ability of a protein involved in lung and thyroid cancer

Research conducted at the National Cancer Research Centre (CNIO) has revealed an unexpected behavior observed in a protein ...
Medical Xpress

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

In some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical study with a 42-month-long follow-up period, researchers ...